Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media
Go back to Repligen to Acquire BioLife Solutions, Expanding Its Cell Therapy Capabilities with Market Leading Biopreservation Media| BIOLIFE SOLUTIONS (NASDAQ: BLFS) | Delayed: 35.25 -0.28 (0.79%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $35.53 | 52 Week High | $3.58 | |||
| Open | $35.07 | 52 Week Low | $1.43 | |||
| Day High | $35.52 | P/E | N/A | |||
| Day Low | $34.89 | EPS | $0.00 | |||
| Volume | 344,312 | |||||
| Repligen Corp (NASDAQ: RGEN) | Delayed: 167.60 -2.01 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $169.61 | 52 Week High | $33.79 | |||
| Open | $167.26 | 52 Week Low | $20.07 | |||
| Day High | $169.51 | P/E | 239.43 | |||
| Day Low | $165.00 | EPS | $0.70 | |||
| Volume | 806,067 | |||||
